GL1X · GenesisL1 explorer

Research workbench

Discovery of PYRAZOLO[1,5-A]PYRIMIDINE derivative as a highly selective PDE10A inhibitor

Analyse Discovery of PYRAZOLO[1,5-A]PYRIMIDINE derivative as a highly selective PDE10A… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6K9U
Type
protein
Length
302 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A
EC
3.1.4.17, 3.1.4.35
UniProt
Q9QYJ6
Ligands
D4L, ZN, MG, SO4
Pockets
3 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 73% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACamp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17, 3.1.4.35)protein30273% helix, 0% strandQ9QYJ6

Ligands and binding sites

  • D4L · 2-(3,7-dimethylquinoxalin-2-yl)-~{N}-(oxan-4-yl)-5-pyrrolidin-1-yl-pyrazolo[1,5-a]pyrimidin-7-amine · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • MG · Magnesium ion · metal · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14590.740.8350MG, D4L
21070.520.8218empty
3850.400.7820empty

Compared structures

  • 6K9U · Discovery of Pyrazolo[1,5-a]pyrimidine Derivative as a Highly Selective PDE10A Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9QYJ6 · AlphaFold monomer V2.0 prediction for camp and camp-inhibited cgmp 3',5'-cyclic… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.